RIGEL PHARMACEUTICALS, INC. Other Non-Current Liabilities
RIGEL PHARMACEUTICALS, INC. (RIGL) had Other Non-Current Liabilities of $0 as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-03-03
- 2025-12-31: Other Liabilities, Noncurrent $0.00.
- 2025-03-31: Other Liabilities, Noncurrent $39.98M.
- 2024-12-31: Other Liabilities, Noncurrent $39.98M.
- 2024-09-30: Other Liabilities, Noncurrent $39.98M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-03 |
| 2025-03-31 | $39.98M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $39.98M 10-K · filed 2026-03-03 |
| 2024-09-30 | $39.98M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $39.98M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $39.98M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $39.94M 10-K · filed 2025-03-04 |
| 2023-09-30 | $38.76M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $40.98M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $42.06M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $42.26M 10-K · filed 2024-03-05 |
| 2022-09-30 | $48.71M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $46.89M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $53.20M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $52.73M 10-K · filed 2023-03-07 |
| 2021-09-30 | $54.37M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $48.23M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $57.53M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $5.04M 10-K · filed 2022-03-01 |
| 2020-09-30 | $5.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $5.00M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $5.00M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $5.10M 10-K · filed 2021-03-02 |
| 2018-06-30 | $38.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $38.00K 10-Q · filed 2018-05-01 |
| 2017-12-31 | $38.00K 10-K · filed 2019-02-28 |
| 2017-09-30 | $77.00K 10-Q · filed 2017-11-07 |
| 2016-12-31 | $2.00K 10-K · filed 2018-03-06 |
| 2016-09-30 | $8.00K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $15.00K 10-Q · filed 2016-08-02 |
| 2016-03-31 | $21.00K 10-Q · filed 2016-05-03 |
| 2015-12-31 | $27.00K 10-K · filed 2017-03-07 |
| 2015-09-30 | $33.00K 10-Q · filed 2015-11-03 |
| 2015-06-30 | $39.00K 10-Q · filed 2015-08-04 |
| 2015-03-31 | $46.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $51.00K 10-K · filed 2016-03-08 |
| 2014-09-30 | $57.00K 10-Q · filed 2014-11-04 |
| 2014-06-30 | $63.00K 10-Q · filed 2014-08-05 |
| 2014-03-31 | $69.00K 10-Q · filed 2014-05-07 |
| 2013-12-31 | $74.00K 10-K · filed 2015-03-03 |
| 2013-09-30 | $80.00K 10-Q · filed 2013-11-05 |
| 2013-06-30 | $85.00K 10-Q · filed 2013-08-06 |
| 2013-03-31 | $91.00K 10-Q · filed 2013-05-07 |
| 2012-12-31 | $96.00K 10-K · filed 2014-03-04 |
| 2012-09-30 | $102.00K 10-Q · filed 2012-11-06 |
| 2012-06-30 | $107.00K 10-Q · filed 2012-08-07 |
| 2012-03-31 | $112.00K 10-Q · filed 2012-05-01 |
| 2011-12-31 | $117.00K 10-K · filed 2013-03-05 |
| 2011-09-30 | $123.00K 10-Q · filed 2011-11-01 |
| 2011-06-30 | $128.00K 10-Q · filed 2011-08-02 |
| 2010-12-31 | $137.00K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |